Abstract
Urticaria, often referred to as hives, is one of the most commonly diagnosed dermatologic disorders in emergency departments and urgent care facilities. Due to the wide variety of manifestations and etiologies, it is of great importance to rapidly recognize the condition, work up potential causes, and institute appropriate clinical treatment. In this chapter we aim to educate clinicians about the etiology, presentation, and management of the three subtypes of urticaria commonly induced by drugs: acute, chronic, and contact urticaria.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Anne S, Middleton Jr E, Reisman RE. Vancomycin anaphylaxis and successful desensitization. Ann Allergy. 1994;73(5):402–4.
Autegarden JE, Pecquet C, Huet S, Bayrou O, Leynadier F. Anaphylactic shock after application of chlorhexidine to unbroken skin. Contact Dermatitis. 1999;40(4):215.
Bandino JP, Thoppil J, Kennedy JS, Hivnor CM. Iatrogenic autoimmune progesterone dermatitis caused by 17alpha-hydroxyprogesterone caproate for preterm labor prevention. Cutis. 2011;88(5):241–3.
Bennett MJ, Anderson LK, McMillan JC, Ebertz JM, Hanifin JM, Hirshman CA. Anaphylactic reaction during anaesthesia associated with positive intradermal skin test to fentanyl. Can Anaesth Soc J. 1986;33(1):75–8.
Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol. 2001;137(6):765–70.
Bindslev-Lensen C, Finzi A, Greaves M, Camarasa J, Ortonne JP, Schopf E, et al. Chronic urticaria: diagnostic recommendations. J Eur Acad Dermatol Venereol. 2000;14(3):175–80.
Bingham CO III. New onset urticaria. In: Callen J, FA, Saini S, editors. UpToDate. Waltham. 2014. http://www.uptodate.com/contents/new-onset-urticaria. Accessed 03 Oct 2014.
Bologna JL, Jorizzo JL, Rapini RP, editors. Dermatology. St. Louis: Mosby Elsevier; 2003. p. 335–6.
Caubet JC, Kaiser L, Lemaitre B, Fellay B, Gervaix A, Eigenmann PA. The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge. J Allergy Clin Immunol. 2011;127(1):218–22.
Champion RH, Roberts SO, Carpenter RG, Roger JH. Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol. 1969;81(8):588–97.
Cousin F, Philips K, Favier B, Bienvenu J, Nicolas JF. Drug-induced urticaria. Eur J Dermatol. 2001;11(3):181–7.
Grattan CE, Sabroe RA, Greaves MW. Chronic urticaria. J Am Acad Dermatol. 2002;46(5):645–57; quiz 57–60.
Grattan CEH. Urticaria and angioedema. In: Bolognia J, Jorizzo J, Rapini RP, editors. Dermatology. St. Louis: Mosby Elsevier; 2013. p. 291–306.
Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000;105(4):664–72.
Grimm V, Rakoski J, Ring J. Urticaria and angioedema induced by COX-2 inhibitors. J Allergy Clin Immunol. 2002;109(2):370.
Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med. 1992;117(3):234–42.
Juhlin L. Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol. 1981;104(4):369–81.
Kaplan AP. Chronic urticaria and angioedema. N Engl J Med. 2002;346(3):175–9.
Kaplan AP, Greaves M. Pathogenesis of chronic urticaria. Clin Exp Allergy. 2009;39(6):777–87.
Knowles SR, Drucker AM, Weber EA, Shear NH. Management options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivity. Ann Pharmacother. 2007;41(7):1191–200.
Kozel MM, Mekkes JR, Bossuyt PM, Bos JD. The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema. Arch Dermatol. 1998;134(12):1575–80.
Krautheim AB, Jermann TH, Bircher AJ. Chlorhexidine anaphylaxis: case report and review of the literature. Contact Dermatitis. 2004;50(3):113–6.
Lopez Saez MP, de Barrio M, Zubeldia JM, Prieto A, Olalde S, Baeza ML. Acute IgE-mediated generalized urticaria-angioedema after topical application of povidone-iodine. Allergol Immunopathol (Madr). 1998;26(1):23–6.
Mathelier-Fusade P. Drug-induced urticarias. Clin Rev Allergy Immunol. 2006;30(1):19–23.
Molinaro G, Cugno M, Perez M, Lepage Y, Gervais N, Agostoni A, et al. Angiotensin-converting enzyme inhibitor-associated angioedema is characterized by a slower degradation of des-arginine(9)-bradykinin. J Pharmacol Exp Ther. 2002;303(1):232–7.
Mortureux P, Leaute-Labreze C, Legrain-Lifermann V, Lamireau T, Sarlangue J, Taieb A. Acute urticaria in infancy and early childhood: a prospective study. Arch Dermatol. 1998;134(3):319–23.
Nosbaum A, Braire-Bourrel M, Dubost R, Faudel A, Parat S, Nicolas JF, et al. Prevention of nonsteroidal inflammatory drug-induced urticaria and/or angioedema. Ann Allergy Asthma Immunol. 2013;110(4):263–6.
Oyvin IA, Gaponyuk PY, Volodin VM, Oyvin VI, Tokaryev OY. Mechanisms of blood vessel permeability derangement under the influence of permeability factors (histamine, serotonin, kinins) and inflammatory agents. Biochem Pharmacol. 1972;21(1):89–95.
Pechlaner C, Knapp E, Wiedermann CJ. Hypersensitivity reactions associated with recombinant tissue-type plasminogen activator and urokinase. Blood Coagul Fibrinolysis. 2001;12(6):491–4.
Peroni A, Colato C, Schena D, Girolomoni G. Urticarial lesions: if not urticaria, what else? The differential diagnosis of urticaria: part I. Cutaneous diseases. J Am Acad Dermatol. 2010;62(4):541–55; quiz 55–6.
Quiralte J, Delgado J, Pedro B, Lopez-Pascual E, Nieto MA, Ortega N, et al. Safety of the new selective cyclooxygenase type 2 inhibitors rofecoxib and celecoxib in patients with anaphylactoid reactions to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol. 2004;93(4):360–4.
Robledo T, Cimarra M, Agustin P, Martinez-Cocera C. Adverse reaction to dextromethorphan. Allergy. 2004;59(8):890.
Salkind AR, Cuddy PG, Foxworth JW. The rational clinical examination. Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy. JAMA. 2001;285(19):2498–505.
Sanchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am J Clin Dermatol. 2002;3(9):599–607.
Sharif S, Goldberg B. Detection of IgE antibodies to bacitracin using a commercially available streptavidin-linked solid phase in a patient with anaphylaxis to triple antibiotic ointment. Ann Allergy Asthma Immunol. 2007;98(6):563–6.
Sheldon JM, Mathews KP, Lovell RG. The vexing urticaria problem: present concepts of etiology and management. J Allergy. 1954;25(6):525–60.
Shipley D, Ormerod AD. Drug-induced urticaria. Recognition and treatment. Am J Clin Dermatol. 2001;2(3):151–8.
Waton J, Boulanger A, Trechot PH, Schmutz JL, Barbaud A. Contact urticaria from Emla cream. Contact Dermatitis. 2004;51(5–6):284–7.
Zembowicz A, Mastalerz L, Setkowicz M, Radziszewski W, Szczeklik A. Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. Arch Dermatol. 2003;139(12):1577–82.
Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau A, et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009;64(10):1417–26.
Zuberbier T, Maurer M. Urticaria: current opinions about etiology, diagnosis and therapy. Acta Derm Venereol. 2007;87(3):196–205.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag London
About this chapter
Cite this chapter
Shaath, T.S., Patel, V.K., Rajpara, A.N., Fraga, G.R., Aires, D.J. (2015). Drug-Induced Urticaria. In: Hall, J., Hall, B. (eds) Cutaneous Drug Eruptions. Springer, London. https://doi.org/10.1007/978-1-4471-6729-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4471-6729-7_6
Publisher Name: Springer, London
Print ISBN: 978-1-4471-6728-0
Online ISBN: 978-1-4471-6729-7
eBook Packages: MedicineMedicine (R0)